Overall rank by patents
#47,583
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, active 2015–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES).
The verdict
ID holds 5 US patents across 11 technology areas, rank #47,583 of 50,000 tracked assignees.
ID Lab has been granted 5 US utility patents between 2015 and 2020, placing ID Lab at rank #47,583 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.4 claims per patent with primary concentration in A41D (OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES). As a Foreign Corporation, ID Lab is one of the more focused assignees in the PatentsView dataset. By volume, ID sits between ICB Pharma Spolka Jawna Tomasz Swietoslawski, Pawel Swietoslawski (5 patents, rank #47,579) and IDM Tooling, Llc (5 patents, rank #47,587) - the closest US assignees by grant volume. The composite Innovation Score of 30.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 4 in the 2015–2019 window, a -75% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. ID Lab's 21.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ID Lab against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ICB PHARMA SPOLKA JAWNA TOMASZ SWIETOSLAWSKI, PAWEL SWIETOSLAWSKI
5 patents
ICE HOUSE AMERICA, LLC
5 patents
ICE IP S.A.
5 patents
ICON Clinical Research Limited
5 patents
ID Quantique
5 patents
IDE Water Technologies LTD
5 patents
IDID TECNOLOGIA LTDA
5 patents
IDM Tooling, LLC
5 patents
ID Lab
5 patents
What this shows ID holds 5 patents at rank #47,583, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,583 in granted patent volume.
Other assignees with the most granted patents in ID's primary technology class.
ID's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 65% higher than 35% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 40.0% |
| 2016 | 1 | 20.0% |
| 2017 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
Top 11 of 11 technology areas
Overall rank by patents
#47,583
Across all tracked assignees
30.8 out of 100
How to use this portfolio
ID's 5 grants land it in the top 65% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.